Impact of the Initiation of Balloon Pulmonary Angioplasty Program on Referral of Patients with Chronic Thromboembolic Pulmonary Hypertension to Surgery
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but severe complication of acute pulmonary embolism leading to right heart failure and premature mortality. Its cumulative incidence ranges from 0.1 –9.1% within the first 2 years after symptomatic acute pulmonary embolism, although probably underestimated due to the lack of systematic follow-up and screening in clinical routine.1–3
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Myriam Amsallem, Julien Guihaire, Jennifer Arthur Ataam, Lilia Lamrani, David Boulate, Sacha Mussot, Dominique Fabre, Yu Taniguchi, Francois Haddad, Olivier Sitbon, Xavier Jais, Marc Humbert, G érald Simonneau, Olaf Mercier, Philippe Brenot, Elie Fadel Tags: Original Clinical Science Source Type: research
More News: Angioplasty | Baloon Angioplasty | Cardiology | Heart | Heart Failure | Heart Transplant | Hypertension | Lung Transplant | Pulmonary Hypertension | Pulmonary Thromboembolism | Science | Transplants